Therapeutic targets in inflammatory bowel disease
Therapeutic goals in inflammatory bowel disease (IBD) have evolved with the introduction of biologic therapies. These medications have demonstrated that resolution of mucosal inflammation was feasible. Mucosal healing has been associated with fewer complications and better patient outcomes. Hence, s...
Main Authors: | Daniela Fluxa, Maria T. Abreu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-07-01
|
Series: | Revista Médica Clínica Las Condes |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0716864019300616 |
Similar Items
-
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
by: Peyrin-Biroulet, L, et al.
Published: (2015) -
Special Issue “Gut Microbiota, Inflammatory Bowel Diseases, and Therapeutic Targets”
by: Eirini Filidou, et al.
Published: (2023-05-01) -
RIPK2 as a New Therapeutic Target in Inflammatory Bowel Diseases
by: Hajime Honjo, et al.
Published: (2021-04-01) -
APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease
by: Lauren Sahakian, et al.
Published: (2023-10-01) -
Inflammasome-targeting natural compounds in inflammatory bowel disease: Mechanisms and therapeutic potential
by: Qiuyun Xu, et al.
Published: (2022-08-01)